- EDWARDS LIFESCIENCES TO PRESENT AT THE BERNSTEIN 38TH ANNUAL STRATEGIC DECISIONS CONFERENCE
- EDWARDS ANNOUNCES KEY EVENTS FOR EUROPCR 2022
- EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS
- EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON APRIL 26, 2022
- EDWARDS MITRIS RESILIA VALVE RECEIVES FDA APPROVAL FOR MITRAL REPLACEMENT SURGERIES
More ▼
Key statistics
On Wednesday, Edwards Lifesciences Corp (EW:NYQ) closed at 96.85, 5.82% above its 52-week low of 91.52, set on May 12, 2022.
52-week range
Markit short selling activity
Open | 94.21 |
---|---|
High | 97.20 |
Low | 93.60 |
Bid | 95.65 |
Offer | 97.30 |
Previous close | 94.54 |
Average volume | 2.76m |
---|---|
Shares outstanding | 621.75m |
Free float | 616.95m |
P/E (TTM) | 38.75 |
Market cap | 58.78bn USD |
EPS (TTM) | 2.44 USD |
Data delayed at least 15 minutes, as of May 25 2022 21:00 BST.
More ▼